The "ecstasy" hangover: hyponatremia due to 3,4-methylenedioxymethamphetamine (Q36274846)

13 August 2017

The "ecstasy" hangover: hyponatremia due to 3,4-methylenedioxymethamphetamine (English)

1 reference

13 August 2017

1 reference

1 reference

1 reference

13 August 2017

Lewis S Nelson

0 references

Stephen J Traub

1 reference

13 August 2017

1 December 2002

1 reference

13 August 2017

Journal of Urban Health

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

549-555

1 reference

The role of V2 vasopressin antagonists in hyponatremia

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Vasopressin V2 receptor antagonists

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Water: normal balance, hyponatremia, and hypernatremia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Drug-induced syndrome of inappropriate antidiuretic hormone secretion

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Selective serotonin reuptake inhibitors and hyponatraemia: review and proposed mechanisms in the elderly

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Hyponatraemia and catatonic stupor after taking "ecstasy".

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Ecstasy: a common cause of severe acute hepatotoxicity

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Low-dose MDMA ("ecstasy") induces vasopressin secretion

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Psychological effects of MDE in normal subjects. Are entactogens a new class of psychoactive agents?

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Hyponatraemia after ingestion of ecstasy

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Hyperpyrexia and rhabdomyolysis after MDMA ("ecstasy") abuse

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Treatment of hyponatremic encephalopathy with antagonists to antidiuretic hormone

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Delayed rhabdomyolysis after ecstasy use.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Death from hyponatraemia-induced cerebral oedema associated with MDMA ("Ecstasy") use.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Hyponatraemia and seizures after ecstasy use.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Hyponatraemia, seizures and stupor associated with ecstasy ingestion in a female.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Severe hyponatremia and inappropriate antidiuretic hormone secretion following ecstasy use.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Mood and cognitive effects of ± 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’): week‐end ‘high’ followed by mid‐week low

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Delayed severe rhabdomyolysis after taking 'ecstasy'.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3456731

Hyponatraemic coma after ecstasy ingestion

22 September 2018

1 reference

12 December 2020

Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans

1 reference

12 December 2020

Syndrome of inappropriate antidiuretic hormone secretion and "designer drugs" (ecstasy)

1 reference

12 December 2020

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 6-2001. A 17-year-old girl with marked jaundice and weight loss

1 reference

12 December 2020

Inappropriate antidiuretic hormone secretion and extreme rises in serum creatinine kinase following MDMA ingestion

1 reference

12 December 2020

Near-fatal hyponatraemic coma due to vasopressin over-secretion after "ecstasy" (3,4-MDMA)

1 reference

12 December 2020

Hyponatraemia and death after "ecstasy" ingestion

1 reference

12 December 2020

Identifiers

DOI

10.1093/JURBAN/79.4.549

1 reference

PMC publication ID

3456731

Dimensions Publication ID

13 August 2017

0 references

1 reference

PMC publication ID

3456731

13 August 2017

PubMed publication ID

12468674

1 reference

PMC publication ID

3456731